Related references
Note: Only part of the references are listed.Lack of T1 hyperintensity in the dentate nucleus after 15 administrations of a macrocyclic contrast agent in multiple sclerosis
Philipp Eisele et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years
Marie-Luise Kromrey et al.
EUROPEAN RADIOLOGY (2017)
Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
Gregor Jost et al.
EUROPEAN RADIOLOGY (2017)
Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging
Zheyu Shen et al.
MOLECULAR PHARMACEUTICS (2017)
Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
Jessica Lohrke et al.
INVESTIGATIVE RADIOLOGY (2017)
Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images Comparison of Gadodiamide and Gadoxetic Acid
Shintaro Ichikawa et al.
INVESTIGATIVE RADIOLOGY (2017)
Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats
Marlene Rasschaert et al.
INVESTIGATIVE RADIOLOGY (2017)
Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobe
J. Gallo et al.
NANOSCALE (2017)
Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children (vol 47, pg 1345, 2017)
Maria Camilla Rossi Espagnet et al.
PEDIATRIC RADIOLOGY (2017)
Clearance of Gadolinium from the Brain with No Pathologic Effect after Repeated Administration of Gadodiamide in Healthy Rats: An Analytical and Histologic Study
Adrian P. L. Smith et al.
RADIOLOGY (2017)
Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging
Thomas F. Flood et al.
RADIOLOGY (2017)
Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent
Alexander Radbruch et al.
RADIOLOGY (2017)
Intracranial Gadolinium Deposition Following Gadodiamide-Enhanced Magnetic Resonance Imaging in Pediatric Patients: A Case-Control Study
Jennifer S. McDonald et al.
JAMA PEDIATRICS (2017)
Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression
Andrey A. Bobko et al.
SCIENTIFIC REPORTS (2017)
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2017)
T1 Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents
Zaw Aung Khant et al.
MAGNETIC RESONANCE IN MEDICAL SCIENCES (2017)
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
J. Ramalho et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?
Jacob Agris et al.
EUROPEAN RADIOLOGY (2016)
Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol
Dragan A. Stojanov et al.
EUROPEAN RADIOLOGY (2016)
Macrocyclic Gadolinium-Based Contrast Agents Do Not Cause Hyperintensity in the Dentate Nucleus
T. Kanda et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol
Yan Cao et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
Moshe Rogosnitzky et al.
BIOMETALS (2016)
Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast
Masami Tanaka et al.
EUROPEAN NEUROLOGY (2016)
Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide
Joana Ramalho et al.
EUROPEAN RADIOLOGY (2016)
Impact of Impaired Renal Function on Gadolinium Retention After Administration of Gadolinium-Based Contrast Agents in a Mouse Model
A. Adhipatria P. Kartamihardja et al.
INVESTIGATIVE RADIOLOGY (2016)
Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents Comparison of Linear and Macrocyclic Agents
Gregor Jost et al.
INVESTIGATIVE RADIOLOGY (2016)
Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function
Nozomu Murata et al.
INVESTIGATIVE RADIOLOGY (2016)
Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
Philippe Robert et al.
INVESTIGATIVE RADIOLOGY (2016)
Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration
Joana Ramalho et al.
MAGNETIC RESONANCE IMAGING (2016)
Are some agents less likely to deposit gadolinium in the brain?
Alexander Radbruch
MAGNETIC RESONANCE IMAGING (2016)
Gadolinium deposition in the brain: Lessons learned from other metals known to cross the blood-brain barrier
John P. Prybylski et al.
MAGNETIC RESONANCE IMAGING (2016)
Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study
Philipp Eisele et al.
MEDICINE (2016)
Blood-Brain Barrier Permeability and Gadolinium Benefits and Potential Pitfalls in Research
Axel Montagne et al.
JAMA NEUROLOGY (2016)
Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration
M. E. Adin et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Diagnosis of Nephrogenic Systemic Fibrosis by means of Elemental Bioimaging and Speciation Analysis
Marvin Birka et al.
ANALYTICAL CHEMISTRY (2015)
Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: Role of pharmaceutical formulation
Nathalie Fretellier et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy
Carlo Cosimo Quattrocchi et al.
INVESTIGATIVE RADIOLOGY (2015)
Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration
Lukas D. Weberling et al.
INVESTIGATIVE RADIOLOGY (2015)
T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats Difference Between Linear and Macrocyclic Agents
Philippe Robert et al.
INVESTIGATIVE RADIOLOGY (2015)
Nanoparticle-based multimodal PET/MRI probes
Joel Garcia et al.
NANOMEDICINE (2015)
In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites
Leyong Zeng et al.
NANOSCALE (2015)
Tuning the relaxation rates of dual-mode T-1/T-2 nanoparticle contrast agents: a study into the ideal system
Natasha A. Keasberry et al.
NANOSCALE (2015)
MRI Brain Signal Intensity Changes of a Child During the Course of 35 Gadolinium Contrast Examinations
Jeffrey H. Miller et al.
PEDIATRICS (2015)
High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents
Joana Ramalho et al.
RADIOLOGY (2015)
Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent
Alexander Radbruch et al.
RADIOLOGY (2015)
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy
Tomonori Kanda et al.
RADIOLOGY (2015)
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
Robert J. McDonald et al.
RADIOLOGY (2015)
Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging
Yi-Xiang J. Wang
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Do ASARM peptides play a role in nephrogenic systemic fibrosis?
Peter S. N. Rowe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update
Jean-Marc Idee et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation
Yuri Errante et al.
INVESTIGATIVE RADIOLOGY (2014)
High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material
Tomonori Kanda et al.
RADIOLOGY (2014)
Stimulation of Fibroblast Proliferation by Insoluble Gadolinium Salts
Katherine Bleavins et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2012)
Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging
Joel Garcia et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2012)
Ultrasmall water-soluble metal-iron oxide nanoparticles as T-1-weighted contrast agents for magnetic resonance imaging
Leyong Zeng et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2012)
Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis-an autopsy-based review
Soma Sanyal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Manganese-based MRI contrast agents: past, present, and future
Dipanjan Pan et al.
TETRAHEDRON (2011)
Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy
Daniel Xia et al.
ACTA RADIOLOGICA (2010)
Oxidatively Stable, Aqueous Europium(II) Complexes through Steric and Electronic Manipulation of Cryptand Coordination Chemistry
Nipuni-Dhanesha H. Gamage et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis
S. J. George et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Self-Confirming AND Logic Nanoparticles for Fault-Free MRI
Jin-sil Choi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Iron, Copper, and Zinc Distribution of the Cerebellum
Bogdan F. Gh. Popescu et al.
CEREBELLUM (2009)
Primer on Gadolinium Chemistry
A. Dean Sherry et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Biodistribution of Gadolinium-Based Contrast Agents, Including Gadolinium Deposition
Silvio Aime et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Secondary Hyperparathyroidism: Pathophysiology and Treatment
Wissam Saliba et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2009)
Incorporation of excess gadolinium into human bone from medical contrast agents
Thomas H. Darrah et al.
METALLOMICS (2009)
Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences:: a critical review
Marc Port et al.
BIOMETALS (2008)
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions
Martin A. Sieber et al.
EUROPEAN RADIOLOGY (2008)
A preclinical study to investigate the development of nephrogenic systemic fibrosis: A possible role for gadolinium-based contrast media
Martin A. Sieber et al.
INVESTIGATIVE RADIOLOGY (2008)
Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C
Thomas Frenzel et al.
INVESTIGATIVE RADIOLOGY (2008)
Dermal inorganic gadolinium concentrations:: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis
J. L. Abraham et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
On the rate and extent of drug delivery to the brain
Margareta Hammarlund-Udenaes et al.
PHARMACEUTICAL RESEARCH (2008)
What nephrologists need to know about gadolinium
Jeffrey G. Penfield et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
Peter Marckmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
T Grobner
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative-to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy
GW White et al.
INVESTIGATIVE RADIOLOGY (2006)
Extensive cerebrospinal fluid enhancement following gadolinium chelate administration: Possible pathogenesis
HL Hsu et al.
ACTA RADIOLOGICA (2005)
Comparison of Gd DTPA-BMA (Omniscan) versus GdHP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy
WA Gibby et al.
INVESTIGATIVE RADIOLOGY (2004)
Silencing of phosphonate-gadolinium magnetic resonance Imaging contrast by hydroxyapatite binding
FC Alves et al.
INVESTIGATIVE RADIOLOGY (2003)